Bloomberg Technology
AI Drug-Discovery Firm Chai Raises $130 Million Series B
Chai Discovery, an AI drug-discovery startup, raises a $130 million Series B at a $1.3 billion valuation, with plans to build a “computer-aided design suite” for molecules. Chai Discovery co-founder Joshua Meier and investor Elena Viboch, managing director at General Catalyst, join Caroline Hyde on “Bloomberg Tech.” ——– Like this video? Subscribe to Bloomberg Technology…
